- Home
- AMRN vs FLC Comparison
AMRN vs FLC Comparison
Compare AMRN & FLC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMRN
- FLC
- Stock Information
- Founded
- AMRN 1989
- FLC 2003
- Country
- AMRN Ireland
- FLC United States
- Employees
- AMRN N/A
- FLC N/A
- Industry
- AMRN Biotechnology: Pharmaceutical Preparations
- FLC Trusts Except Educational Religious and Charitable
- Sector
- AMRN Health Care
- FLC Finance
- Exchange
- AMRN Nasdaq
- FLC Nasdaq
- Market Cap
- AMRN 189.2M
- FLC 180.6M
- IPO Year
- AMRN 1993
- FLC N/A
- Fundamental
- Price
- AMRN $0.52
- FLC $16.59
- Analyst Decision
- AMRN Buy
- FLC
- Analyst Count
- AMRN 1
- FLC 0
- Target Price
- AMRN N/A
- FLC N/A
- AVG Volume (30 Days)
- AMRN 1.8M
- FLC 37.8K
- Earning Date
- AMRN 02-27-2025
- FLC 01-01-0001
- Dividend Yield
- AMRN N/A
- FLC 6.64%
- EPS Growth
- AMRN N/A
- FLC N/A
- EPS
- AMRN N/A
- FLC N/A
- Revenue
- AMRN $241,021,000.00
- FLC N/A
- Revenue This Year
- AMRN N/A
- FLC N/A
- Revenue Next Year
- AMRN N/A
- FLC N/A
- P/E Ratio
- AMRN N/A
- FLC N/A
- Revenue Growth
- AMRN N/A
- FLC N/A
- 52 Week Low
- AMRN $0.43
- FLC $12.62
- 52 Week High
- AMRN $1.37
- FLC $15.45
- Technical
- Relative Strength Index (RSI)
- AMRN 53.40
- FLC 44.20
- Support Level
- AMRN $0.43
- FLC $16.46
- Resistance Level
- AMRN $0.49
- FLC $16.89
- Average True Range (ATR)
- AMRN 0.03
- FLC 0.22
- MACD
- AMRN 0.01
- FLC -0.01
- Stochastic Oscillator
- AMRN 62.36
- FLC 36.00
About AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About FLC Flaherty & Crumrine Total Return Fund Inc
Flaherty & Crumrine Total Return Fund Inc is a diversified, closed-end investment management company. Its investment objective is to provide its common shareholders with a high current income. The fund's secondary investment objective is capital appreciation.